bioRxivCancer BiologyPreprint
An autoregulatory feedback loop converging on H2A ubiquitination drives synovial sarcoma
N. S. Benabdallah, V. Dalal, A. Sotiriou, R. W. Scott, F. K. Kommoss, A. Pejkovska, L. Gaspar, L. Wagner, F. J. Sanchez-Rivera, M. Ta, S. Thornton, T. O. Nielsen, T. M. Underhill, A. Banito
Abstract
The SS18-SSX fusion drives oncogenic transformation in synovial sarcoma by bridging SS18, a member of mSWI/SNF complex, to Polycomb repressive complex 1 (PRC1) target genes. Here we show that the SSX C-terminus, via its SSXRD domain, directs SS18-SSX chromatin binding independently of SS18. SSXRD specific targeting is mediated by interaction with mono ubiquitinated H2A (H2AK119ub1) and histone MacroH2A with which the fusion overlaps genome wide. Variant Polycomb Repressive Complex 1.1 (PRC1.1) acts as the main depositor of H2AK119ub1 and is therefore required for SS18-SSX occupancy. Importantly, the SSX C-terminus not only depends on H2AK119ub1 for localization but also further increases it by promoting PRC1.1 complex stability. Consequently, high H2AK119ub1 levels are a feature of murine and human synovial sarcomas. These results reveal an SSX/PRC1 autoregulatory feedback loop that reinforces fusion chromatin binding and therefore its oncogenic activity, and could play a role in a wider range of cancers and physiological settings where SSX proteins are overexpressed.
- organism: mouse
- organism: human
- assay: ChIP-seq
- assay: DNA methylation
- research focus: chromatin & epigenetic regulation
- research focus: cell type annotation
- research focus: gene regulatory network inference
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synovial Sarcoma X Breakpoint 1 Protein uses a cryptic groove to selectively recognize H2AK119Ub Nucleosomes
Zebin Tong, Huasong Ai, … Lei Liu·Nature Structural & Molecular BiologyPeer-reviewed·Jan 4, 2024
- SS18::SSX redistributes BAF chromatin remodelers selectively to activate and repress transcription
Jinxiu Li, Li Li, … Kevin B. Jones·bioRxiv·May 14, 2024
- SUMO2 Inhibition Reverses Aberrant Epigenetic Rewiring Driven by Synovial Sarcoma Fusion Oncoproteins and Impairs Sarcomagenesis
Rema Iyer, Anagha J. Deshpande, … Aniruddha J. Deshpande·The EMBO JournalPeer-reviewed·Aug 13, 2025
- Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial Sarcoma
Konstantinos V. Floros, Carter K. Fairchild, … Anthony C. Faber·Nature CommunicationsPeer-reviewed·Nov 5, 2025
- SS18-SSX co-opts P300 to sustain oncogenic transcription independent of SWI/SNF activity
Anthony M. Doherty, Eimear Lagan, … Gerard L. Brien·bioRxiv·Jan 27, 2026
- BAF complex-independent gene activation by SS18::SSX
Afroditi Sotiriou, Jinxiu Li, … Ana Banito·bioRxiv·Jan 27, 2026